Henlius Partners With Getz To Commercialize Adalimumab Biosimilar
Companies Plan To Cover 11 Emerging Markets In Asia, Africa And Europe
• By Akriti Seth
Shanghai Henlius Biotech and Pakistan based Getz Pharma partner to commercialize adalimumab biosimilar in emerging markets • Source: Alamy 
